baber/WOPTO huggingface dataset:
Patent AU-5119179-A (AU)
Title: Self-curing polyalkylacrylate composition
Inventor: SEIDEL HARTMUT
IPC: C08F265/06
Filed: 1979-09-26
Abstract: Self-curing compositions are prepared based on polymethyl methacrylate (PMMA) are by mixing a finely powdered solid polymer phase of PMMA and/or poly (2-hydroxyethyl methacrylate) (PHEMA) with a liquid monomer phase of methyl methacrylate (MMA) and/or 2-hydroxyethyl methacrylate (HEMA) in a weight ratio of polymer phase to monomer phase of 1.5 to 3.3:1 wherein the portion of PHEMA in the cured product is between 2 and 99 weight %. The product is prepared by vigorously stirring the mixture at room temperature until the polymerization is essentially finished.
Patent AU-5141285-A (AU)
Title: Aminobenzamide derivatives
Inventor: MIKI TOSAKU
IPC: C07C233/65
Filed: 1985-12-18
Abstract: Aminobenzamide derivatives of the formula (I)wherein:R<sub>1</sub> and R<sub>2</sub> each represents a lower alkoxy group,R<sub>3</sub> represents a hydrogen atom, a lower alkyl group, a lower acyl group, a lower alkoxycarbonyl group or -R<sub>5</sub>-S0<sub>3</sub>Z, wherein R<sub>5</sub> represents a lower alkylene group and Z represents an alkali metal or an alkaline earth metal,R<sub>4</sub> represents an amino group, a morpholino group or a lower alkylamino group which may be substituted with a hydroxyl group at the alkyl moiety thereof, with the proviso that, when R<sub>3</sub> represents a hydrogen atom, R<sub>4</sub> cannot be an amino group,Y represents a hydrogen atom, a halogen atom or a lower alkoxy group,n represents an integer of from 1 to 6, and salts thereof; are disclosed. These compounds have excellent anti-peptic ulcer activities, and are chemically and physically stable.
Patent AU-5270093-A (AU)
Title: Resin laminate
Inventor: TANAKA HIROSHI
IPC: A61J1/10
Filed: 1993-12-24
Abstract: A resin laminate comprising: an outer layer formed from a linear polyethylene having a density from 0.910 to 0.950 g/cm<3>; an inner layer formed from a linear polyethylene having a density of not more than 0.940 g/cm<3>; and an intermediate layer or layers between the outer and inner layers, at least one intermediate layer comprising a linear polyethylene having a density not more than 0.920 g/cm<3>; at least one of the outer, inner and intermediate layers is formed from a linear polyethylene composition containing a high-density polyethylene and a container formed from the resin laminate. The resin laminate is excellent in hygienic qualities, transparency, flexibility and heat resistance.
Patent AU-5550996-A (AU)
Title: Drug document production system
Inventor: UMEN MICHAEL J
IPC: G16H10/20
Filed: 1996-04-17
Abstract: A method of producing a document for regulatory approval of a medical product, comprising entering data objects pertaining to a study of the medical product into a database, providing a document format defining delimited data fields for insertion of data objects, providing a user interface for selection of the data objects to be included in the document, extracting data objects pertaining to the study from the database, using the extracted data objects as defined by the document format to generate the document compatible with a document publishing system, and publishing the generated document. The invention also relates to an apparatus for computer-aided composition and generation of a medical product document. <IMAGE>
Patent AU-5567594-A (AU)
Title: Valve for the treatment of hydrocephalus
Inventor: JEAN-BAPTISTE DREVET
IPC: G05D16/20
Filed: 1993-11-30
Abstract: PCT No. PCT/FR93/01176 Sec. 371 Date May 17, 1995 Sec. 102(e) Date May 17, 1995 PCT Filed Nov. 30, 1993 PCT Pub. No. WO94/12222 PCT Pub. Date Jun. 9, 1994A device for regulating the flow of an organic liquid between a production site and a resorption site of a patient in a drainage circuit that extends between the two sites, one of the sites being a site of small pressure variation and the other being a site of large pressure variation, particularly as a function of the position of the subject, the device comprising a valve for implanting beneath the skin and connected by a first duct to one of the sites and by a second cut to the other site, the valve comprising a body (1) defining an internal passage inter-connecting the two ducts, a member (14) for adjusting the section of said passage, and control means (7, 15) coupled to said adjustment member (14) to displace it between a first position in which the passage is closed and second positions in which the passage is opened to a controlled extent, the device being characterized in that the control means comprise a first chamber (12) formed in the body (1) and closed in sealed manner by a moving wall (7), a second chamber (6) formed in the body and separated from the first by the moving wall (7), which second chamber forms a portion (2) of the interconnecting passage and is connected to the duct (3) coming from the site having small pressure variation, means for coupling the moving wall (7) to the adjustment member (14), resilient means (17, 21) for returning the adjustment member towards its position in which it closes the interconnecting passage, and means for adjusting the magnitude of the return force.
Patent AU-5884998-A (AU)
Title: Heating element for a water-bed
Inventor: BOERTJENS ABRAM JAN
IPC: A47C27/08
Filed: 1998-02-03
Abstract: PCT No. PCT/NL98/00067 Sec. 371 Date Aug. 6, 1999 Sec. 102(e) Date Aug. 6, 1999 PCT Filed Feb. 3, 1998 PCT Pub. No. WO98/36664 PCT Pub. Date Aug. 27, 1998A heating element for heating a water-bed comprising a metal support plate having a high coefficient of thermal conductivity, a heat source attached to the metal support plate and having an electrically resistive conductor which emits heat when electricity passes through it, and an electrical insulator for insulating the heat source from the metal plate.
Patent AU-5947086-A (AU)
Title: Pesticidal compounds
Inventor: PEEK ROBERT JOHN
IPC: C07C327/38
Filed: 1986-06-30
Abstract: Pesticidal compositions for use against insects and acarines comprising a compound of Formula (I):wherein R' is:C<sub>1-14</sub> alkyl optionally substituted by C<sub>1-6</sub> alkoxy,C<sub>2-6</sub> alkenyl, C<sub>2-6</sub> alkynyl, C<sub>2-6</sub> alkenyloxy, C<sub>2-6</sub> alkynyloxy, aryl, aryloxy or aryl (C<sub>1-6</sub>) alkoxy; aryloxy or aryl (C<sub>1-6</sub>) alkoxy; any of which groups may be substituted by halo,n is 1 or 2,each A and A' is independently hydrogen, halo, C<sub>1-4</sub> alkyl or halo (C<sub>1-4</sub>) alkyland R<sup>2</sup> and R<sup>3</sup> are independently hydrogen, C<sub>1-6</sub> alkyl or C<sub>3-6</sub> cycloalkyl, either of which may be substituted by one or more of halo, C<sub>2-6</sub> alkenyl, C<sub>1-6</sub> alkyl, C<sub>3-6</sub> cycloalkyl, C<sub>3-6</sub> cycloalkenyl, C<sub>1-6</sub> alkoxy, C<sub>2</sub>-<sub>6</sub> alkynil or cyano, except that, when n is 1 and R<sup>2</sup> is alkyl and R<sup>3</sup> is hydrogen and A and A' are both hydrogen then R' is not unsubstituted alkyl.Most of the compounds fo Formula (I) are novel.
Patent AU-6054490-A (AU)
Title: Balloon tamponade devices and methods for their placement
Inventor: ZIMMON DAVID S
IPC: A61M25/10
Filed: 1990-06-28
Abstract: Balloon tamponade devices for treating bleeding sites within the upper digestive tract (e.g. esophageal or upper gastric bleeding sites, or duodenal, pyloric or distal gastric bleeding sites) comprise a tube having proximal and distal open ends and at least one inflatable balloon mounted over the tube. Preferably, two balloons are mounted over the tube, and inflation lumens are provided for each. A bridle is attached to the tube, and is adapted to extend up the esophagus to allow the device to be secured in place having the proximal open end of the tube positioned within the digestive tract to allow for normal feeding and swallowing functions. A method for placing a balloon tamponade device as generally described above is also described. The device is backloaded onto an endoscope by passing the endoscope through the open ends of the tube. The endoscope is then passed through the mouth and down the esophagus and used to examine the esophagus and/or other portions of the digestive tract to determine whether or not treatment is required. If treatment is required, the device is advanced along the endoscope and down the esophagus, and the balloon(s) of the device is (are) positioned and inflated to treat the bleeding sites. The endoscope is used to check positioning and then withdrawn. Thereafter, the bridal can be positioned through the nose and connected to a traction device. Methods for delivering detachable coatings to bleeding sites for treatment thereof are also described.
Patent AU-6126290-A (AU)
Title: Gibbon ape leukemia virus receptor
IPC: C12N15/12
Filed: 1990-08-23
Abstract: The present invention relates to the gibbon ape leukemia virus (GALV) receptor protein and the methods for regulating viral entry into cells.
Patent AU-6140786-A (AU)
Title: Alternator assembly
Inventor: THOMAS IORWERTH
IPC: H02K11/00
Filed: 1986-07-16
Abstract: An alternator assembly having a rotor winding (18, 20) and a stator winding (38, 40) and an associated output rectifier (24), the stator winding (38, 40) being located in outwardly facing slots in a laminated iron stator core.
Patent AU-6196198-A (AU)
Title: Improved air control system for an air bed
Inventor: SHAFER DAVID C
IPC: H04Q7/06
Filed: 1998-04-16
Abstract: An automatic controlling the firmness of a fluid supported mattress (14) of a bed assembly (10). The control system includes a motorised fluid pump, a control unit (44) for operating the pump to adjust the firmness of the air mattress (14), a hand held remote control unit (42) for actuating the control unit (44). The air control system provides for independent control of both bladders (30,32) in a two bladder air mattress (14) from a single unit (44), and allows a user to consistently set the firmness of each mattress air bladder (30,32) to a desired value. The air control system includes an air pump specially designed to minimise transmission of motor noise into the environment.
Patent AU-6246790-A (AU)
Title: Thrombolytic composition containing tissue type plasminogen activator or derivative thereof
IPC: A61K38/49
Filed: 1990-09-13
Abstract: A thrombolytic composition containing tissue type plasminogen activator or a derivative thereof in combination with an anionic polymer or a salt thereof and an amine compound or a salt thereof or in combination with an anionic polymer or a salt thereof, an amine compound and an acid or a salt thereof. The composition is an aqueous solution or a lyophilized preparation which can be stably dissolved on dilution at near neutral pH in both pharmaceutical solutions having high salt concentrations, such as physiological saline, and pharmaceutical solutions having low salt concentrations, such as a 5% glucose solution. Clinically useful products for infusion or injection are prepared to be used at a pH bear neutral.
Patent AU-6469780-A (AU)
Title: Polymerizing vinyl chloride
Inventor: BJERKE O
IPC: C08F2/22
Filed: 1980-11-25
Abstract: The present invention comprises a method of preparing vinyl chloride polymers or vinyl chloride copolymers suitable for the preparation of plastisols. The method can be used at polymerizations, wherein a pre-emulsion of a substance having a very low solubility in water, is caused to swell by the vinyl chloride monomer, whereafter the monomer emulsion abtained is subjected to polymerizing conditions. According to the invention the emulsion is stabilized, and, by polymerizing in the presence of an stabilizing latex, it is possible to avoid, that the obtained latex becomes instable. In this way it is possible to prepare polymers having a particle size and a particle size distribution giving a product with low viscosity at the preparation of plastisols.
Patent AU-6530494-A (AU)
Title: Gonococcal anti-idiotypic antibodies and methods and compositions using them
Inventor: RICE PETER A
IPC: A61P31/04
Filed: 1994-04-06
Abstract: The present invention relates to anti-idiotypic antibodies directed against Neisseria gonorrhoeae. This invention also relates to methods and compositions using such anti-idiotypic antibodies for the prophylaxis, treatment and diagnosis of gonorrheal infections.
Patent AU-6605386-A (AU)
Title: Novel catalyst systems for the preparation of foams containing isocyanurate and urethane linkages
Inventor: ELING BEREND
IPC: C08G18/16
Filed: 1986-12-03
Abstract: The invention relates to the preparation of polymer foams containing urethane and isocyanurate linkages by the use of a catalyst system based on an alkali metal or tetraalkylammonium carboxylate and a group IIa metal carboxylate.
Patent AU-6682598-A (AU)
Title: Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs
Inventor: PANET AMOS
IPC: C07K7/06
Filed: 1998-03-04
Abstract: The subject invention provides novel peptides and the use of these peptides in the treatment of various diseases and conditions. The novel peptides specifically bind to undetermined and determined targets in various organs and in lymphocytes. The subject invention also provides a method for the identification of a peptide by applying peptide library methodology ex vivo to perfused organs.
Patent AU-6728298-A (AU)
Title: Oligonucleotides that can be used in the amplification and detection of cmv nucleic acid
Inventor: SILLEKENS PETER THEODORUS GERA
IPC: C12Q1/68
Filed: 1998-02-25
Abstract: The sensitivity and reliability (robustness) of CMV mRNA detection are greatly dependent on the selection of suitable oligonucleotides for amplification, since there is sequence variation among strains of CMV potentially in every region of the genome. The present invention is concerned with oligonucleotides that can be used as in the amplification and detection of human Cytomegalovirus (HCMV) mRNA. These novel oligonucleotides show an improved sensitivity and robustness of CMV mRNA detection if compared with known sequences when used in amplification and detection. Furthermore a method for the diagnosis of HCMV disease is provided.
Patent AU-6795787-A (AU)
Title: Magnesia partially-stabilized zirconia
Inventor: BUSH EDWARD ALLEN
IPC: C04B35/48
Filed: 1987-01-23
Abstract: A partially stabilised zirconia body consists of crystalline zirconia contg. 0.05-0.5 wt.% of silica and 2-5-4 wt.% magnesia. It has a structure of cubic zirconia with discrete ppts. of tetragonal and monoclinic zirconia those ppts. having an ellipsoidal shape with a long dimension of 0.1-0.4 micron. The body is characterised by specified values of rupture modulus after thermal shock and coefft of thermal expansion according to whether the monoclinic phase is present in the range 10-20 vol.% or 20-60 vol.%. The green body is sintered at 1525-1800 deg.C, cooled at controlled rate to 1300-1450 deg.C; cooled at a controlled rate to 1000-1200 deg.C and optionally aged; cooled to room temp., optionally reheated to 1000-1200 deg.C and aged. Total ageing time is 10-150 hours.
Patent AU-6814901-A (AU)
Title: Methods and compounds for controlled release of recombinant parvovirus vectors
Inventor: MONAHAN PAUL E
IPC: A61K35/76
Filed: 2001-06-01
Abstract: The invention uses recombinant parvoviruses, and particularly recombinant adeno-associated virus (rAAV) to deliver genes and DNA sequences for gene therapy following manipulation of the therapeutic virus for packaging and transport. The invention delivers therapeutic viral vectors via rAAV affixed to support matrixes (i.e., sutures, surgically implantable materials, grafts, and the like).
Patent AU-6992894-A (AU)
Title: Case-storage device
Inventor: REINHARD ALFRED
IPC: B65D85/575
Filed: 1994-07-05
Abstract: PCT No. PCT/CH94/00142 Sec. 371 Date Mar. 29, 1995 Sec. 102(e) Date Mar. 29, 1995 PCT Filed Jul. 5, 1994 PCT Pub. No. WO95/30224 PCT Pub. Date Nov. 9, 1995A device for the storage of cassettes, specifically CD-cassettes, formed of a wall assembly of a plurality of identical bar elements (1) with plug and bores at their planar end areas (5) and pin for connecting the bar elements in a staggered manner having gaps. The bar elements (1) form in a preferred kind at a rack-like arrangement of respective two pairs of bar elements (1) transversely over two bar elements (1) located below and at a stacking above each other in several layers a tower-like rack (10) with slide-in compartments (11) formed by the gaps for one respective cassette (9) between two respective bar elements (1) located above each other. Each bar element includes at the steplike stepped inner longitudinal side (6) at the center an abutment (7) formed by the step for limiting the slide-in path of the cassettes to be slid in from the opposite side. By way of the bar elements any arbitrary frame height for an optimal utilization of given space condition can be produced.
Patent AU-7048281-A (AU)
Title: Conveyor belt
Inventor: HARTMAN K
IPC: B65G15/42
Filed: 1981-05-12
Abstract: 1. An endless conveyor belt comprising of an elongated flexible bottom wall ; and a pair of flexible upright longitudinally extending side walls extending upwardly from said bottom wall at opposite lateral sides thereof, forming a box or a trough like cross-section adapted to accomodate material to be conveyed, said side walls having respective series of longitudinally consecutive upright corrugations each provided with two mutually inclined flanks one of which is inclined with reference to the elongation of said bottom wall at a greater angle than the other flank forming a saw tooth like corrugation.
Patent AU-7105898-A (AU)
Title: Tissue decellularization
Inventor: GOLDSTEIN STEVEN
IPC: C12N5/06
Filed: 1998-04-10
Abstract: The present invention relates, in general, to tissue decellularization and, in particular to a method of treating tissues, for example, heart valves, tendons and ligaments, so as to render them acellular and thereby limit mineralization and/or immunoreactivity upon implementation in vivo.
Patent AU-7189691-A (AU)
Title: Bacterial peptide fraction with an immunostimulatory effect, process for making it and its use
Inventor: PULVERER GERHARD
IPC: C12P21/00
Filed: 1991-02-05
Abstract: The bacterial peptide fraction with immunostimulatory effect may be obtained from commensalic or symbiotic micro-organisms belonging to the physiological microflora of the digestive tract, the skin or the respiratory tract of humans and animals by breeding in customary nutrient media, separating the water-soluble peptides with a molecular weight of under 10 000 D from the biomass and separating in a Sephadex G-25 column with water as the elutrient.
Patent AU-7307496-A (AU)
Title: Water-redispersible granules including a liquid active material and a non-ionic alkoxyl-type surfactant
Inventor: GUERIN GILLES
IPC: C09K23/42
Filed: 1996-10-23
Abstract: PCT No. PCT/FR96/01653 Sec. 371 Date Apr. 24, 1998 Sec. 102(e) Date Apr. 24, 1998 PCT Filed Oct. 23, 1996 PCT Pub. No. WO97/15385 PCT Pub. Date May 1, 1997Water-redispersible granules including at least one active material in the form of a hydrophobic liquid, at least one non-ionic surfactant selected from polyoxyalkylene derivatives, and at least one water-soluble compound selected from polyelectrolytes belonging to the weak polyacid family are disclosed. A method for preparing such granules by preparing an aqueous emulsion of at least one active material, at least one non-ionic surfactant and at least one water-soluble compound, and drying the resulting emulsion, is also disclosed.
Patent AU-7312394-A (AU)
Title: Superoxide dismutase-4
Inventor: YU GUO-LIANG
IPC: A61K48/00
Filed: 1994-05-31
Abstract: Disclosed is a superoxide dismutase-4 (SOD-4) polypeptide and polynucleotides encoding such SOD-4 polypeptides. Also provided is a process for producing such polypeptide by recombinant techniques. Furthermore disclosed is a nucleic acid molecule specifically hybridizing to a polynucleotide encoding such polypeptide and antibodies against such polypeptide as well as the use of such nucleic acid molecules and antibodies for diagnosis. Such SOD-4 polypeptides may be combined with a suitable pharmaceutical carrier to provide therapeutical and/or prophylactic effects against various diseases.
Patent AU-7448701-A (AU)
Title: Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose
Inventor: POLA PIETRO
IPC: A23L33/15
Filed: 2001-06-01
Abstract: A method for treating myocardial or skeletal muscle anoxia which occurs in coronary or post-infarct disorders or during prolonged physical activity and muscle fatigue. This method comprises the administration of a combination composition comprising (a) an alkanoyl L-carnitine selected from the group consisting of isovaleryl L-carnitine, propionyl L-carnitine or the pharmacologically acceptable salts thereof or mixtures thereof; and (b) ribose or a phosphate derivative thereof.
Patent AU-7557496-A (AU)
Title: Ca(oh)2 particles
Inventor: LANGELIN HENRI RENE
IPC: B01D53/50
Filed: 1996-10-18
Abstract: The present invention is a Ca(OH)2 particle composition and a method of making the composition, the composition consisting essentially of dried calcium hydroxide particles having a moisture content of less than 2 percent by weight of the total composition, a specific surface area greater than 30 m2/g, a total nitrogen desorption pore volume of at least 0.1 cm3/g, and a CO2 content of less than 2 percent by weight of the total composition, the aforementioned particles being in the form of a mixture comprising first fraction of particles having a size of less than 32 micrometers and a second fraction of particles of a size greater than 32 micrometers, the weight percent of the second fraction ranging from 20 to 50 percent, the aforementioned particles having a nitrogen desorption pore volume consisting of pores with a diameter ranging from 100 to 400 Angstroms.
Patent AU-7637196-A (AU)
Title: Administration media for analgesic, antiinflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs
Inventor: MEYER PETRUS JOHANNES
IPC: A61K33/00
Filed: 1996-11-13
Abstract: Administration mediums comprising solutions of nitrous oxide in water, alcohols, ethers or oils, and optionally including essential fatty acids or C1-C6 alkyl esters thereof enhance the action of analgesic, anti-inflammatory and anti-pyretic drugs. The drugs may be combined with the medium into a pharmaceutical composition or may be taken orally by swallowing the drug with the aid of the medium.
Patent AU-7643094-A (AU)
Title: Methods of prolonged suppression of humoral immunity
Inventor: NOELLE RANDOLPH J
IPC: A61K35/18
Filed: 1994-09-02
Abstract: Methods of suppressing a humoral immune response to a thymus-dependent (TD) antigen are disclosed. The methods involve administering to a subject a TD antigen with an antagonist of a molecule which mediates contact-dependent helper effector functions. In a preferred embodiment, the antagonist is an antagonist of gp39. Primary and secondary humoral immune responses can be suppressed and suppression is prolonged.